Home›Stock Screener›Auro Laboratories›Quarterly Results

Auro Laboratories Quarterly Results

Latest Quarter Net Profit
₹1 Cr
QSept 2025
Quarterly Results

Auro Laboratories quarterly results. In Sept 2025, Auro Laboratories (AUROLAB) reported revenue ₹10 Cr and net profit ₹1 Cr — revenue +233.3% YoY. For annual financials, live price and key ratios, visit AUROLAB screener.

AUROLAB Quarterly Results — Revenue, Profit & EPS Highlights

Auro Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View Auro Laboratories 52-week for the annual high/low range and current price position.

  • Revenue of ₹10 Cr in Sept 2025 (+233.3% vs Jun 2025, +233.3% vs Sept 2024)
  • Net Profit of ₹1 Cr in Sept 2025
  • EBITDA of ₹3 Cr in Sept 2025
  • Operating Margin of 27.0% in Sept 2025 (+26.0pp vs Jun 2025)
  • Earnings Per Share of ₹1.15 in Sept 2025 (+776.5% vs Jun 2025)

Auro Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AUROLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Jun 2025 Sept 2024 Jun 2024 QoQ YoY
Revenue (₹ Cr) 10 3 3 6 233.3% 233.3%
Net Profit (₹ Cr) 1 0 0 1 - -
EBITDA (₹ Cr) 3 0 1 2 - -
EPS (₹) 1.15 -0.17 0.57 1.21 - -
Operating Margin (%) 27.0% 1.0% 23.0% 23.0% - -

AUROLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Auro Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore Auro Laboratories stock price data download to track price trends across different timeframes.

Profitability Ratios

Profit Margin 10.0%
EBITDA Margin 30.0%
Operating Margin 27.0%
ROE (Annual) 8.7%

Balance Sheet Highlights

Total Assets ₹121 Cr
Total Equity ₹46 Cr
Current Assets ₹ Cr
Current Liabilities ₹46 Cr

Cash Flow Analysis

Operating Cash Flow ₹2 Cr
Investing Cash Flow ₹-15 Cr
Financing Cash Flow ₹14 Cr
Net Cash Flow ₹1 Cr

Current Market Data

Current Price ₹247.60
Exchange BSE
Last Updated Nov 20, 2026

AUROLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Auro Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1884.9 16,617 1,995 +10.6% - 12.0% 227.1
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11180.5 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4689.5 4,111 364 +27.7% +42.2% 8.9% 407.4
Apollo Hospitals
Sept 2026
₹132,281.88 Cr 9200.0 7,673 660 +15.2% - 8.6% 209.9
Laurus Labs
Sept 2026
₹125,946.78 Cr 2294.6 2,219 436 +21.7% - 19.6% 280.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores